News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
745,616 Results
Type
Article (44539)
Company Profile (322)
Press Release (700741)
Multimedia
Podcasts (121)
Webinars (19)
Section
Business (211843)
Career Advice (2130)
Deals (36896)
Drug Delivery (125)
Drug Development (83809)
Employer Resources (177)
FDA (16971)
Job Trends (15571)
News (359238)
Policy (34766)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2634)
Accelerated approval (33)
Adcomms (26)
Allergies (149)
Alliances (51824)
ALS (176)
Alzheimer's disease (1693)
Antibody-drug conjugate (ADC) (324)
Approvals (17230)
Artificial intelligence (539)
Autoimmune disease (157)
Automation (39)
Bankruptcy (372)
Best Places to Work (11804)
BIOSECURE Act (22)
Biosimilars (197)
Biotechnology (190)
Bladder cancer (157)
Brain cancer (61)
Breast cancer (649)
Cancer (4894)
Cardiovascular disease (417)
Career advice (1805)
Career pathing (37)
CAR-T (290)
CDC (47)
Celiac Disease (2)
Cell therapy (762)
Cervical cancer (37)
Clinical research (71459)
Collaboration (1764)
Company closure (4)
Compensation (1172)
Complete response letters (64)
COVID-19 (2803)
CRISPR (95)
C-suite (869)
Cystic fibrosis (148)
Data (6264)
Decentralized trials (2)
Denatured (36)
Depression (134)
Diabetes (510)
Diagnostics (6790)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (263)
Drug pricing (207)
Drug shortages (31)
Duchenne muscular dystrophy (235)
Earnings (92183)
Editorial (63)
Employer branding (22)
Employer resources (156)
Events (120729)
Executive appointments (1002)
FDA (20121)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1488)
Gene editing (203)
Generative AI (46)
Gene therapy (619)
GLP-1 (1022)
Government (5076)
Grass and pollen (7)
Guidances (384)
Healthcare (19218)
HIV (59)
Huntington's disease (45)
IgA nephropathy (88)
Immunology and inflammation (263)
Immuno-oncology (58)
Indications (111)
Infectious disease (3073)
Inflammatory bowel disease (195)
Inflation Reduction Act (14)
Influenza (116)
Intellectual property (254)
Interviews (333)
IPO (16958)
IRA (57)
Job creations (4110)
Job search strategy (1517)
JPM (64)
Kidney cancer (16)
Labor market (85)
Layoffs (584)
Leadership (33)
Legal (8524)
Liver cancer (93)
Longevity (15)
Lung cancer (656)
Lymphoma (380)
Machine learning (43)
Management (60)
Manufacturing (825)
MASH (169)
Medical device (13915)
Medtech (13968)
Mergers & acquisitions (21013)
Metabolic disorders (1314)
Multiple sclerosis (160)
NASH (17)
Neurodegenerative disease (322)
Neuropsychiatric disorders (91)
Neuroscience (2955)
Neurotech (1)
NextGen: Class of 2026 (6675)
Non-profit (4604)
Now hiring (67)
Obesity (622)
Opinion (292)
Ovarian cancer (167)
Pain (216)
Pancreatic cancer (229)
Parkinson's disease (285)
Partnered (34)
Patents (505)
Patient recruitment (495)
Peanut (60)
People (61147)
Pharmaceutical (90)
Pharmacy benefit managers (31)
Phase 1 (22148)
Phase 2 (31384)
Phase 3 (23572)
Pipeline (5320)
Policy (302)
Postmarket research (2703)
Preclinical (9407)
Press Release (68)
Prostate cancer (242)
Psychedelics (50)
Radiopharmaceuticals (289)
Rare diseases (870)
Real estate (6342)
Recruiting (73)
Regulatory (25682)
Reports (52)
Research institute (2455)
Resumes & cover letters (365)
Rett syndrome (27)
RNA editing (18)
RSV (77)
Schizophrenia (156)
Series A (244)
Series B (193)
Service/supplier (12)
Sickle cell disease (99)
Special edition (24)
Spinal muscular atrophy (164)
Sponsored (43)
Startups (3784)
State (2)
Stomach cancer (18)
Supply chain (107)
Tariffs (97)
The Weekly (83)
Vaccines (1042)
Venture capital (91)
Weight loss (411)
Women's health (91)
Worklife (18)
Date
Today (21)
Last 7 days (593)
Last 30 days (2044)
Last 365 days (30320)
2026 (3497)
2025 (30746)
2024 (35870)
2023 (40724)
2022 (51908)
2021 (56495)
2020 (55016)
2019 (47771)
2018 (36061)
2017 (33290)
2016 (32871)
2015 (38781)
2014 (32704)
2013 (27828)
2012 (29909)
2011 (30637)
2010 (28674)
Location
Africa (820)
Alabama (83)
Alaska (7)
Arizona (317)
Arkansas (14)
Asia (42365)
Australia (6792)
California (11364)
Canada (3333)
China (1141)
Colorado (480)
Connecticut (479)
Delaware (340)
Europe (91185)
Florida (1696)
Georgia (355)
Hawaii (3)
Idaho (62)
Illinois (879)
India (69)
Indiana (532)
Iowa (22)
Japan (442)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1392)
Massachusetts (8187)
Michigan (327)
Minnesota (633)
Mississippi (5)
Missouri (135)
Montana (32)
Nebraska (28)
Nevada (123)
New Hampshire (79)
New Jersey (3021)
New Mexico (29)
New York (2996)
North Carolina (1479)
North Dakota (8)
Northern California (5542)
Ohio (335)
Oklahoma (22)
Oregon (46)
Pennsylvania (2301)
Puerto Rico (24)
Rhode Island (48)
South America (1188)
South Carolina (67)
South Dakota (1)
Southern California (4423)
Tennessee (175)
Texas (1755)
United States (40405)
Utah (337)
Vermont (1)
Virginia (276)
Washington D.C. (82)
Washington State (930)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
745,616 Results for "novartis pharmaceuticals canada inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Teva Canada Announces Strategic Partnership with Novartis Canada to Relaunch Mayzent® for Multiple Sclerosis Patients in Canada
February 2, 2026
·
2 min read
Press Releases
Novartis Canada Welcomes Dimitri Gitas as New Country President
November 26, 2025
·
1 min read
Press Releases
Kye Pharmaceuticals Announces Licensing and Distribution Agreement with Neurim Pharmaceuticals for SLENYTO® in Canada
January 13, 2026
·
5 min read
Press Releases
Novartis Canada Unveils 2025 Health Equity Initiative Winners, Awarding Over $560,000 at Montreal Ceremony with Federal Health Minister, the Honourable Marjorie Michel, in Attendance
November 28, 2025
·
5 min read
Pipeline
Novartis Cuts 6 Early Cancer Candidates, Adds 2 to Refine Oncology Strategy
Despite the Phase 1 cull, CEO Vas Narasimhan on Wednesday maintained that Novartis continues to invest in its early-stage pipeline, looking for deals in the “sub-$2-billion range.”
February 5, 2026
·
2 min read
·
Tristan Manalac
Earnings
Novartis Sticks With M&A Strategy of Building Early Pipeline, Searching for Near-Launches
Novartis will still be on the lookout for early-stage deals under $2 billion, and later-stage agreements around a product that could reach the market within five years, CEO Vas Narasimhan said Wednesday.
February 4, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Cipher Pharmaceuticals Announces Health Canada’s Acceptance for Review of New Drug Submission for Natroba™ (Spinosad)
January 29, 2026
·
7 min read
Radiopharmaceuticals
Novartis’ Pluvicto Heavywork Proves Radiopharma Can Succeed
While investment has slowed in radiopharmaceuticals, analysts predict increased interest to come as Novartis shows just how successful radiopharmaceuticals can be.
November 6, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome
February 5, 2026
·
8 min read
Press Releases
Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®
November 13, 2025
·
4 min read
1 of 74,562
Next
